Form No M-3 (6)
1.
2.
Course title: Topical Issues in Clinical Pharmacology
Course code: FLK_009
3.
Academic unit: Department of Pharmacology , Hiprokrāta iela 2, Hiprokrāta iela 2,
Rīga, LV-1002, phone: +371 67042338; e-mail:
[CourseImplementerEmail]
4.
5.
Head of the academic unit:
Course author:
Santa Purviņa, e-mail: Santa.Purvina@rsu.lv
Dr. med., Associate Professor Santa Purviņa, Santa.Purvina@rsu.lv
6.
Teaching staff involved in implementation of the study course: Asoc. prof. S.
Purviņa, Asist.p.i.L.Zariņa, Asist.p.i. M.Tirzīte, Asist.p.i. E.Krustiņš, Asist.p.i. A.Mihailova,
Asoc.prof. D.Baltiņa
7.
Faculty, study programme, year of studies and semester: International Student
Department Second Level Professional higher education study programme „Medicine”
8.
9.
Number of LV credit points
Number of ECTS points
(KP) : 2
(1KP = 1.5 ECTS): 3
10.
Language: English
11.
Course type (compulsory, restricted elective, elective) : B - Restricted elective course
12.
Prerequisites: To know different internal medicine diseases pathogenesis and treatment principles as well as pharmacology.
13.
Course objective: To know different internal medicine diseases pathogenesis and treatment principles as well as pharmacology.
14.
Topic outline of the study course:
15.
Students’ independent work and tasks:
before each lesson revision of the themes on pharmacology and pharmacotherapy as well as information of drugs, their use and the treatment process selection and analysis.
16.
Learning outcomes:
 knowledge: Students will gain additional knowledge on antihypertensive medication groups, diabetes treatment, glucocorticoid and mineralocorticoid, nonsteroidal antiinflammatory drugs, coronary active drugs, inotropic drugs and diuretics, anti-arrhythmic agents, antibiotics and broncholytics.
 practical skills: on completion of the study course the students will be able to explain the mechanism of action of certain drugs, predict events, and be able to explain the clinical exposure of the disease mechanisms and pathogenesis, the choice of the specific situation in an appropriate medication dosing scheme and evaluate the risks and benefits of treatment, will be able to prescribe appropriate pharmacotherapy for pathology.

Form No M-3 (6)
 competence: 1.Use theoretical knowledge and clinical expertise in pharmacology;
2.Describe the preparations pharmacological classes;
3.Formulate mechanisms of action indications, contraindications and side effects;
4.Will be able to use the knowledge gained pharmacotherapy to describe the pharmacotherapeutic groups;
5.To administrate appropriate pharmacotherapy, to justify the choice of the drug was administered;
6.Based on the evidence-based medical data, to evaluate drug therapy relation to age, gender and comorbidity, drug selection, and evaluate the risk and benefit balance.
17.
Type of final examination (examination, semester test, theoretical test, National examination) : Test
18.
Assessment criteria: The final examination- test after series of lectures and practical classes.
19.
Readings:

Recommended:
1. Katzung B. Basic and Clinical Pharmacology. Last Edition. Appleton & Lange
British National Formulary (March 2008)
2. Ievads farmakovigilancē. ZVA 2005.
3. V.Liguts, Toksikoloģijas rokasgrāmata, 2001.
4. Neatliekamā medicīniskā palīdzība D.Krieviņa redakcijā. Atdzīvināšana. 2003.

Optional:
1. http://www.vm.gov.lv
2. http://www. EMCDDA.europa.eu/
3. http://www. euphix.org/
4. http://ec.europa.eu/health-eu/
5. http://www. haiweb.org/

Other sources:
[CourseInformationSources]